This company listing is no longer active
REM Stock Overview
Remedis SA provides financial management services to health care institutions and local government units. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Remedis SA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | zł0.08 |
| 52 Week High | zł0.09 |
| 52 Week Low | zł0.04 |
| Beta | 1.0 |
| 1 Month Change | 0% |
| 3 Month Change | -11.11% |
| 1 Year Change | 100.00% |
| 3 Year Change | -41.61% |
| 5 Year Change | 166.67% |
| Change since IPO | -91.11% |
Recent News & Updates
Recent updates
Shareholder Returns
| REM | PL Diversified Financial | PL Market | |
|---|---|---|---|
| 7D | 0% | -3.2% | 0.09% |
| 1Y | 100.0% | -24.0% | -4.7% |
Return vs Industry: REM exceeded the Polish Diversified Financial industry which returned 25.1% over the past year.
Return vs Market: REM exceeded the Polish Market which returned 24.7% over the past year.
Price Volatility
| REM volatility | |
|---|---|
| REM Average Weekly Movement | n/a |
| Diversified Financial Industry Average Movement | 4.0% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in PL Market | 8.9% |
| 10% least volatile stocks in PL Market | 3.2% |
Stable Share Price: REM has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine REM's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 3 | Marcin Wyszogrodzki | remedis.eu |
Remedis SA provides financial management services to health care institutions and local government units. It offers financing, capital investment, consultancy, and restructuring services. The company is based in Poznan, Poland.
Remedis SA Fundamentals Summary
| REM fundamental statistics | |
|---|---|
| Market cap | zł5.06m |
| Earnings (TTM) | -zł2.32m |
| Revenue (TTM) | n/a |
-6.6x
P/S Ratio-2.2x
P/E RatioIs REM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| REM income statement (TTM) | |
|---|---|
| Revenue | -zł769.09k |
| Cost of Revenue | zł712.00 |
| Gross Profit | -zł769.80k |
| Other Expenses | zł1.55m |
| Earnings | -zł2.32m |
Last Reported Earnings
Mar 31, 2023
Next Earnings Date
Nov 10, 2023
| Earnings per share (EPS) | -0.037 |
| Gross Margin | 100.09% |
| Net Profit Margin | 301.03% |
| Debt/Equity Ratio | 3,397.0% |
How did REM perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/11/04 05:25 |
| End of Day Share Price | 2023/08/07 00:00 |
| Earnings | 2023/03/31 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Remedis SA is covered by 0 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|